Get the latest tech news

Riding the GLP-1 boom, VITL lands $7.5M to overhaul cash-pay clinic prescribing

The startup provides an e-prescribing marketplace for the booming cash-pay clinic market.

None

Related news:

Pfizer ended up passing on my GLP-1 work back in the early '90s (2024)

From blood sugar to brain relief: GLP-1 therapy slashes migraine frequency

There may not be a safe off-ramp for some taking GLP-1 drugs, study suggests